Term,Overlap,P.value,Adjusted.P.value,Old.P.value,Old.Adjusted.P.value,Odds.Ratio,Combined.Score,Genes
connective tissue development (GO:0061448),3/38,3.635471092298182e-5,0.01661410289180269,0,0,55.108755760368666,563.3319936811033,SPTLC2;ZBTB16;CD44
negative regulation of inclusion body assembly (GO:0090084),2/10,1.251535470990176e-4,0.02859758551212552,0,0,155.921875,1401.1091659987735,DNAJB1;SORL1
positive regulation of protein exit from endoplasmic reticulum (GO:0070863),2/13,2.1624086857684936e-4,0.029403716804920998,0,0,113.38068181818181,956.8329118851915,EDEM1;SORL1
negative regulation of cell adhesion (GO:0007162),3/73,2.573629479642976e-4,0.029403716804920998,0,0,27.505990783410137,227.33765252681698,SPN;CD164;DUSP1
negative regulation of cellular component organization (GO:0051129),3/80,3.372238210031123e-4,0.030752637148790275,0,0,24.996648512777544,199.84229792133095,DNAJB1;HSPA5;SORL1
leukocyte tethering or rolling (GO:0050901),2/18,4.219121242602919e-4,0.030752637148790275,0,0,77.9296875,605.5692748599668,SPN;SELL
leukocyte adhesion to vascular endothelial cell (GO:0061756),2/19,4.710469585153871e-4,0.030752637148790275,0,0,73.34191176470588,561.83958527557,SPN;SELL
chaperone cofactor-dependent protein refolding (GO:0051085),2/26,8.886174067263165e-4,0.05076226935924083,0,0,51.932291666666664,364.8681683209649,DNAJB1;HSPA5
'de novo' posttranslational protein folding (GO:0051084),2/31,0.0012646591825652726,0.06146985471547577,0,0,42.9676724137931,286.72124195111644,DNAJB1;HSPA5
regulation of cell morphogenesis (GO:0022604),2/32,0.001347535310850809,0.06146985471547577,0,0,41.53333333333333,274.5136550437013,PDZD8;CD44
regulation of cell adhesion (GO:0030155),3/133,0.0014795807480749092,0.06146985471547577,0,0,14.766253101736973,96.21685367174459,SPN;CD164;DUSP1
negative regulation of MAP kinase activity (GO:0043407),2/48,0.003012866504729657,0.08893066593454615,0,0,27.065217391304348,157.1098878516162,DUSP1;SORL1
response to unfolded protein (GO:0006986),2/49,0.0031377384221648597,0.08893066593454615,0,0,26.488031914893618,152.6837170661895,DNAJB1;HSPA5
cartilage development (GO:0051216),2/52,0.003526704480067964,0.08893066593454615,0,0,24.895,140.5918093795177,ZBTB16;CD44
negative regulation of protein-containing complex assembly (GO:0031333),2/52,0.003526704480067964,0.08893066593454615,0,0,24.895,140.5918093795177,HSPA5;SORL1
myeloid cell differentiation (GO:0030099),2/52,0.003526704480067964,0.08893066593454615,0,0,24.895,140.5918093795177,ZBTB16;SLC25A5
positive regulation of macroautophagy (GO:0016239),2/53,0.003661116595332141,0.08893066593454615,0,0,24.40563725490196,136.9153101039388,SPTLC2;SLC25A5
IRE1-mediated unfolded protein response (GO:0036498),2/53,0.003661116595332141,0.08893066593454615,0,0,24.40563725490196,136.9153101039388,HSPA5;EDEM1
negative regulation of endopeptidase activity (GO:0010951),2/63,0.005134013003729868,0.08893066593454615,0,0,20.394467213114755,107.51693221862237,SERPINB1;SORL1
ubiquitin-dependent ERAD pathway (GO:0030433),2/73,0.006835572611732835,0.08893066593454615,0,0,17.513204225352112,87.31409431287084,HSPA5;EDEM1
negative regulation of protein serine/threonine kinase activity (GO:0071901),2/78,0.007769694961352618,0.08893066593454615,0,0,16.356907894736842,79.45407878009898,DUSP1;SORL1
protein retention in Golgi apparatus (GO:0045053),1/5,0.008471900201487836,0.08893066593454615,0,0,151.22727272727272,721.5053863184621,SORL1
ADP transport (GO:0015866),1/5,0.008471900201487836,0.08893066593454615,0,0,151.22727272727272,721.5053863184621,SLC25A5
negative regulation of IRE1-mediated unfolded protein response (GO:1903895),1/5,0.008471900201487836,0.08893066593454615,0,0,151.22727272727272,721.5053863184621,HSPA5
hematopoietic stem cell migration (GO:0035701),1/5,0.008471900201487836,0.08893066593454615,0,0,151.22727272727272,721.5053863184621,BCL11B
cellular response to salt stress (GO:0071472),1/5,0.008471900201487836,0.08893066593454615,0,0,151.22727272727272,721.5053863184621,SLC12A6
mannose trimming involved in glycoprotein ERAD pathway (GO:1904382),1/5,0.008471900201487836,0.08893066593454615,0,0,151.22727272727272,721.5053863184621,EDEM1
regulation of mitophagy (GO:1901524),1/5,0.008471900201487836,0.08893066593454615,0,0,151.22727272727272,721.5053863184621,SLC25A5
ubiquitin-dependent glycoprotein ERAD pathway (GO:0097466),1/5,0.008471900201487836,0.08893066593454615,0,0,151.22727272727272,721.5053863184621,EDEM1
protein deglycosylation involved in glycoprotein catabolic process (GO:0035977),1/5,0.008471900201487836,0.08893066593454615,0,0,151.22727272727272,721.5053863184621,EDEM1
regulation of neuron death (GO:1901214),2/86,0.009376849224023898,0.08893066593454615,0,0,14.793154761904763,69.07680592717206,FOS;SORL1
ERAD pathway (GO:0036503),2/87,0.009587327860281597,0.08893066593454615,0,0,14.618382352941177,67.93619932794203,HSPA5;EDEM1
negative regulation of cellular response to hypoxia (GO:1900038),1/6,0.010157908740538318,0.08893066593454615,0,0,120.97575757575757,555.2185648964451,ENO1
regulation of adipose tissue development (GO:1904177),1/6,0.010157908740538318,0.08893066593454615,0,0,120.97575757575757,555.2185648964451,SORL1
negative regulation of meiotic cell cycle (GO:0051447),1/6,0.010157908740538318,0.08893066593454615,0,0,120.97575757575757,555.2185648964451,DUSP1
negative regulation of monocyte chemotaxis (GO:0090027),1/6,0.010157908740538318,0.08893066593454615,0,0,120.97575757575757,555.2185648964451,DUSP1
positive regulation of plasminogen activation (GO:0010756),1/6,0.010157908740538318,0.08893066593454615,0,0,120.97575757575757,555.2185648964451,ENO1
negative regulation of triglyceride metabolic process (GO:0090209),1/6,0.010157908740538318,0.08893066593454615,0,0,120.97575757575757,555.2185648964451,SORL1
choline catabolic process (GO:0042426),1/6,0.010157908740538318,0.08893066593454615,0,0,120.97575757575757,555.2185648964451,SLC44A1
choline transport (GO:0015871),1/6,0.010157908740538318,0.08893066593454615,0,0,120.97575757575757,555.2185648964451,SLC44A1
regulation of mitotic sister chromatid segregation (GO:0033047),1/6,0.010157908740538318,0.08893066593454615,0,0,120.97575757575757,555.2185648964451,DUSP1
regulation of mitotic spindle checkpoint (GO:1903504),1/6,0.010157908740538318,0.08893066593454615,0,0,120.97575757575757,555.2185648964451,DUSP1
type B pancreatic cell proliferation (GO:0044342),1/6,0.010157908740538318,0.08893066593454615,0,0,120.97575757575757,555.2185648964451,SERPINB1
hemopoiesis (GO:0030097),2/94,0.011119216815215943,0.08893066593454615,0,0,13.501358695652174,60.74369859051535,CD164;ZBTB16
negative regulation of MAPK cascade (GO:0043409),2/94,0.011119216815215943,0.08893066593454615,0,0,13.501358695652174,60.74369859051535,DUSP1;SORL1
regulation of MAP kinase activity (GO:0043405),2/97,0.011806700935729659,0.08893066593454615,0,0,13.073026315789473,58.032314670661705,DUSP1;SORL1
negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901029),1/7,0.011841135434323054,0.08893066593454615,0,0,100.8080808080808,447.2023640851642,SLC25A5
negative regulation of p38MAPK cascade (GO:1903753),1/7,0.011841135434323054,0.08893066593454615,0,0,100.8080808080808,447.2023640851642,DUSP1
cellular hypotonic response (GO:0071476),1/7,0.011841135434323054,0.08893066593454615,0,0,100.8080808080808,447.2023640851642,SLC12A6
mitochondrion-endoplasmic reticulum membrane tethering (GO:1990456),1/7,0.011841135434323054,0.08893066593454615,0,0,100.8080808080808,447.2023640851642,PDZD8
"posttranslational protein targeting to membrane, translocation (GO:0031204)",1/7,0.011841135434323054,0.08893066593454615,0,0,100.8080808080808,447.2023640851642,HSPA5
polyamine biosynthetic process (GO:0006596),1/7,0.011841135434323054,0.08893066593454615,0,0,100.8080808080808,447.2023640851642,AMD1
ammonium transmembrane transport (GO:0072488),1/8,0.013521584565055974,0.08893066593454615,0,0,86.40259740259741,371.8308142207318,SLC12A6
positive regulation of endocytic recycling (GO:2001137),1/8,0.013521584565055974,0.08893066593454615,0,0,86.40259740259741,371.8308142207318,SORL1
positive regulation of muscle contraction (GO:0045933),1/8,0.013521584565055974,0.08893066593454615,0,0,86.40259740259741,371.8308142207318,ENO1
spermidine metabolic process (GO:0008216),1/8,0.013521584565055974,0.08893066593454615,0,0,86.40259740259741,371.8308142207318,AMD1
leukocyte aggregation (GO:0070486),1/8,0.013521584565055974,0.08893066593454615,0,0,86.40259740259741,371.8308142207318,CD44
positive regulation of protein localization to early endosome (GO:1902966),1/8,0.013521584565055974,0.08893066593454615,0,0,86.40259740259741,371.8308142207318,SORL1
positive regulation of protein localization to endosome (GO:1905668),1/8,0.013521584565055974,0.08893066593454615,0,0,86.40259740259741,371.8308142207318,SORL1
T-helper cell lineage commitment (GO:0002295),1/8,0.013521584565055974,0.08893066593454615,0,0,86.40259740259741,371.8308142207318,SPN
TORC1 signaling (GO:0038202),1/8,0.013521584565055974,0.08893066593454615,0,0,86.40259740259741,371.8308142207318,SMG1
regulation of protein localization to early endosome (GO:1902965),1/8,0.013521584565055974,0.08893066593454615,0,0,86.40259740259741,371.8308142207318,SORL1
negative regulation of cellular process (GO:0048523),4/566,0.015026112762600892,0.08893066593454615,0,0,4.60355871886121,19.325581786455896,SPN;CD164;DUSP1;ENO1
positive regulation of ATP biosynthetic process (GO:2001171),1/9,0.01519926045554118,0.08893066593454615,0,0,75.59848484848484,316.4936999007962,ENO1
positive regulation of autophagy of mitochondrion (GO:1903599),1/9,0.01519926045554118,0.08893066593454615,0,0,75.59848484848484,316.4936999007962,SLC25A5
regulation of skeletal muscle cell differentiation (GO:2001014),1/9,0.01519926045554118,0.08893066593454615,0,0,75.59848484848484,316.4936999007962,DDX17
ATF6-mediated unfolded protein response (GO:0036500),1/9,0.01519926045554118,0.08893066593454615,0,0,75.59848484848484,316.4936999007962,HSPA5
regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process (GO:1902959),1/9,0.01519926045554118,0.08893066593454615,0,0,75.59848484848484,316.4936999007962,SORL1
regulation of ER to Golgi vesicle-mediated transport (GO:0060628),1/9,0.01519926045554118,0.08893066593454615,0,0,75.59848484848484,316.4936999007962,SORL1
regulation of PERK-mediated unfolded protein response (GO:1903897),1/9,0.01519926045554118,0.08893066593454615,0,0,75.59848484848484,316.4936999007962,HSPA5
regulation of protein-containing complex assembly (GO:0043254),2/116,0.016577728913190464,0.08893066593454615,0,0,10.883771929824562,44.62014662597905,HSPA5;SORL1
sphingolipid metabolic process (GO:0006665),2/116,0.016577728913190464,0.08893066593454615,0,0,10.883771929824562,44.62014662597905,SPTLC2;ESYT2
receptor recycling (GO:0001881),1/10,0.016874167453351394,0.08893066593454615,0,0,67.1952861952862,274.2892350890436,SORL1
regulation of tau-protein kinase activity (GO:1902947),1/10,0.016874167453351394,0.08893066593454615,0,0,67.1952861952862,274.2892350890436,SORL1
cellular biogenic amine catabolic process (GO:0042402),1/10,0.016874167453351394,0.08893066593454615,0,0,67.1952861952862,274.2892350890436,SLC44A1
regulation of endoplasmic reticulum unfolded protein response (GO:1900101),1/10,0.016874167453351394,0.08893066593454615,0,0,67.1952861952862,274.2892350890436,HSPA5
negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),1/10,0.016874167453351394,0.08893066593454615,0,0,67.1952861952862,274.2892350890436,DNAJB1
chloride ion homeostasis (GO:0055064),1/10,0.016874167453351394,0.08893066593454615,0,0,67.1952861952862,274.2892350890436,SLC12A6
modulation by symbiont of host process (GO:0044003),1/10,0.016874167453351394,0.08893066593454615,0,0,67.1952861952862,274.2892350890436,ENO1
monovalent inorganic anion homeostasis (GO:0055083),1/10,0.016874167453351394,0.08893066593454615,0,0,67.1952861952862,274.2892350890436,SLC12A6
regulation of cellular response to stress (GO:0080135),2/118,0.017120661334831245,0.08893066593454615,0,0,10.695043103448276,43.50175926774057,DNAJB1;SMG1
positive regulation of chondrocyte differentiation (GO:0032332),1/11,0.018546309917010683,0.08893066593454615,0,0,60.472727272727276,241.13405880391542,ZBTB16
positive regulation of cytoplasmic transport (GO:1903651),1/11,0.018546309917010683,0.08893066593454615,0,0,60.472727272727276,241.13405880391542,SORL1
regulation of endocytic recycling (GO:2001135),1/11,0.018546309917010683,0.08893066593454615,0,0,60.472727272727276,241.13405880391542,SORL1
regulation of inclusion body assembly (GO:0090083),1/11,0.018546309917010683,0.08893066593454615,0,0,60.472727272727276,241.13405880391542,DNAJB1
regulation of lamellipodium morphogenesis (GO:2000392),1/11,0.018546309917010683,0.08893066593454615,0,0,60.472727272727276,241.13405880391542,CD44
regulation of lymphocyte migration (GO:2000401),1/11,0.018546309917010683,0.08893066593454615,0,0,60.472727272727276,241.13405880391542,SPN
mesonephros development (GO:0001823),1/11,0.018546309917010683,0.08893066593454615,0,0,60.472727272727276,241.13405880391542,ZBTB16
positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),1/11,0.018546309917010683,0.08893066593454615,0,0,60.472727272727276,241.13405880391542,HSPA5
PERK-mediated unfolded protein response (GO:0036499),1/11,0.018546309917010683,0.08893066593454615,0,0,60.472727272727276,241.13405880391542,HSPA5
protein targeting (GO:0006605),2/125,0.019079982172392113,0.08893066593454615,0,0,10.082825203252032,39.919070023139675,EDEM1;SORL1
adipose tissue development (GO:0060612),1/12,0.020215692219209058,0.08893066593454615,0,0,54.972451790633606,214.4638136267328,SPTLC2
ATP transport (GO:0015867),1/12,0.020215692219209058,0.08893066593454615,0,0,54.972451790633606,214.4638136267328,SLC25A5
regulation of triglyceride catabolic process (GO:0010896),1/12,0.020215692219209058,0.08893066593454615,0,0,54.972451790633606,214.4638136267328,SORL1
negative regulation of leukocyte chemotaxis (GO:0002689),1/12,0.020215692219209058,0.08893066593454615,0,0,54.972451790633606,214.4638136267328,DUSP1
maintenance of protein localization in endoplasmic reticulum (GO:0035437),1/12,0.020215692219209058,0.08893066593454615,0,0,54.972451790633606,214.4638136267328,HSPA5
posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),1/12,0.020215692219209058,0.08893066593454615,0,0,54.972451790633606,214.4638136267328,HSPA5
regulation of plasminogen activation (GO:0010755),1/12,0.020215692219209058,0.08893066593454615,0,0,54.972451790633606,214.4638136267328,ENO1
"energy coupled proton transport, down electrochemical gradient (GO:0015985)",1/12,0.020215692219209058,0.08893066593454615,0,0,54.972451790633606,214.4638136267328,ATP5F1A
positive regulation of multicellular organismal process (GO:0051240),3/345,0.02051457250958738,0.08893066593454615,0,0,5.5529145444255805,21.582067567477132,ZBTB16;ENO1;SORL1
"regulation of retrograde protein transport, ER to cytosol (GO:1904152)",1/13,0.021882318729235836,0.08893066593454615,0,0,50.388888888888886,192.59017962885017,EDEM1
negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),1/13,0.021882318729235836,0.08893066593454615,0,0,50.388888888888886,192.59017962885017,HSPA5
negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),1/13,0.021882318729235836,0.08893066593454615,0,0,50.388888888888886,192.59017962885017,CD44
positive regulation of insulin receptor signaling pathway (GO:0046628),1/13,0.021882318729235836,0.08893066593454615,0,0,50.388888888888886,192.59017962885017,SORL1
negative regulation of mononuclear cell migration (GO:0071676),1/13,0.021882318729235836,0.08893066593454615,0,0,50.388888888888886,192.59017962885017,DUSP1
cellular biogenic amine metabolic process (GO:0006576),1/13,0.021882318729235836,0.08893066593454615,0,0,50.388888888888886,192.59017962885017,AMD1
sphingoid biosynthetic process (GO:0046520),1/13,0.021882318729235836,0.08893066593454615,0,0,50.388888888888886,192.59017962885017,SPTLC2
sphingosine biosynthetic process (GO:0046512),1/13,0.021882318729235836,0.08893066593454615,0,0,50.388888888888886,192.59017962885017,SPTLC2
positive regulation of purine nucleotide biosynthetic process (GO:1900373),1/13,0.021882318729235836,0.08893066593454615,0,0,50.388888888888886,192.59017962885017,ENO1
regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),1/13,0.021882318729235836,0.08893066593454615,0,0,50.388888888888886,192.59017962885017,DUSP1
regulation of protein exit from endoplasmic reticulum (GO:0070861),1/13,0.021882318729235836,0.08893066593454615,0,0,50.388888888888886,192.59017962885017,SORL1
polyamine metabolic process (GO:0006595),1/13,0.021882318729235836,0.08893066593454615,0,0,50.388888888888886,192.59017962885017,AMD1
gene expression (GO:0010467),3/356,0.022263766799781315,0.08893066593454615,0,0,5.376861920862652,20.45785589576623,DDX17;SMG1;SORL1
positive regulation of cellular response to insulin stimulus (GO:1900078),1/14,0.023546193825120534,0.08893066593454615,0,0,46.51048951048951,174.35810878919273,SORL1
"negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",1/14,0.023546193825120534,0.08893066593454615,0,0,46.51048951048951,174.35810878919273,CD44
response to chemokine (GO:1990868),1/14,0.023546193825120534,0.08893066593454615,0,0,46.51048951048951,174.35810878919273,DUSP1
positive regulation of lymphocyte migration (GO:2000403),1/14,0.023546193825120534,0.08893066593454615,0,0,46.51048951048951,174.35810878919273,SPN
regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),1/14,0.023546193825120534,0.08893066593454615,0,0,46.51048951048951,174.35810878919273,CD44
regulation of IRE1-mediated unfolded protein response (GO:1903894),1/14,0.023546193825120534,0.08893066593454615,0,0,46.51048951048951,174.35810878919273,HSPA5
regulation of lamellipodium organization (GO:1902743),1/14,0.023546193825120534,0.08893066593454615,0,0,46.51048951048951,174.35810878919273,CD44
peptidyl-serine dephosphorylation (GO:0070262),1/14,0.023546193825120534,0.08893066593454615,0,0,46.51048951048951,174.35810878919273,DUSP1
androgen receptor signaling pathway (GO:0030521),1/15,0.025207321878441238,0.09142655633688608,0,0,43.18614718614719,158.95183056590525,DDX17
positive regulation of heterotypic cell-cell adhesion (GO:0034116),1/15,0.025207321878441238,0.09142655633688608,0,0,43.18614718614719,158.95183056590525,CD44
integrated stress response signaling (GO:0140467),1/15,0.025207321878441238,0.09142655633688608,0,0,43.18614718614719,158.95183056590525,HSPA5
myoblast differentiation (GO:0045445),1/15,0.025207321878441238,0.09142655633688608,0,0,43.18614718614719,158.95183056590525,DDX17
endoderm development (GO:0007492),1/15,0.025207321878441238,0.09142655633688608,0,0,43.18614718614719,158.95183056590525,DUSP1
negative regulation of programmed cell death (GO:0043069),3/381,0.026536013444734854,0.09254792107054184,0,0,5.014848950332821,18.200152943068968,CCND2;HSPA5;CD44
epiboly involved in wound healing (GO:0090505),1/16,0.02686570725940496,0.09254792107054184,0,0,40.3050505050505,145.77952373263088,CD44
regulation of ATP biosynthetic process (GO:2001169),1/16,0.02686570725940496,0.09254792107054184,0,0,40.3050505050505,145.77952373263088,ENO1
protein localization to endoplasmic reticulum (GO:0070972),1/16,0.02686570725940496,0.09254792107054184,0,0,40.3050505050505,145.77952373263088,HSPA5
establishment of protein localization to endoplasmic reticulum (GO:0072599),1/17,0.028521354338754766,0.09254792107054184,0,0,37.78409090909091,134.401872793062,EDEM1
positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),1/17,0.028521354338754766,0.09254792107054184,0,0,37.78409090909091,134.401872793062,CCND2
negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),1/17,0.028521354338754766,0.09254792107054184,0,0,37.78409090909091,134.401872793062,CD44
mitochondrial ATP synthesis coupled proton transport (GO:0042776),1/17,0.028521354338754766,0.09254792107054184,0,0,37.78409090909091,134.401872793062,ATP5F1A
diol biosynthetic process (GO:0034312),1/17,0.028521354338754766,0.09254792107054184,0,0,37.78409090909091,134.401872793062,SPTLC2
negative regulation of amyloid-beta formation (GO:1902430),1/17,0.028521354338754766,0.09254792107054184,0,0,37.78409090909091,134.401872793062,SORL1
regulation of transcription by RNA polymerase II (GO:0006357),8/2206,0.028618159025789635,0.09254792107054184,0,0,2.487296143347099,8.839138708067189,DDX17;DNAJB1;BCL11B;ZBTB16;ENO1;FOS;SSBP2;MED12L
skeletal system development (GO:0001501),2/158,0.029492956554222155,0.09254792107054184,0,0,7.936698717948718,27.965781801846404,ZBTB16;CD44
organonitrogen compound biosynthetic process (GO:1901566),2/158,0.029492956554222155,0.09254792107054184,0,0,7.936698717948718,27.965781801846404,SLC44A1;SPTLC2
adenine nucleotide transport (GO:0051503),1/18,0.030174267482518016,0.09254792107054184,0,0,35.559714795008915,124.48623298308226,SLC25A5
positive regulation of cartilage development (GO:0061036),1/18,0.030174267482518016,0.09254792107054184,0,0,35.559714795008915,124.48623298308226,ZBTB16
"alternative mRNA splicing, via spliceosome (GO:0000380)",1/18,0.030174267482518016,0.09254792107054184,0,0,35.559714795008915,124.48623298308226,DDX17
glycoprotein catabolic process (GO:0006516),1/18,0.030174267482518016,0.09254792107054184,0,0,35.559714795008915,124.48623298308226,EDEM1
regulation of cartilage development (GO:0061035),1/18,0.030174267482518016,0.09254792107054184,0,0,35.559714795008915,124.48623298308226,ZBTB16
negative regulation of lipid catabolic process (GO:0050995),1/18,0.030174267482518016,0.09254792107054184,0,0,35.559714795008915,124.48623298308226,SORL1
hyaluronan catabolic process (GO:0030214),1/18,0.030174267482518016,0.09254792107054184,0,0,35.559714795008915,124.48623298308226,CD44
intracellular estrogen receptor signaling pathway (GO:0030520),1/18,0.030174267482518016,0.09254792107054184,0,0,35.559714795008915,124.48623298308226,DDX17
negative regulation of signal transduction by p53 class mediator (GO:1901797),1/18,0.030174267482518016,0.09254792107054184,0,0,35.559714795008915,124.48623298308226,CD44
regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),1/18,0.030174267482518016,0.09254792107054184,0,0,35.559714795008915,124.48623298308226,SLC25A5
ATP synthesis coupled proton transport (GO:0015986),1/19,0.031824451052594106,0.09263550401933444,0,0,33.582491582491585,115.77632426352072,ATP5F1A
negative regulation of nervous system development (GO:0051961),1/19,0.031824451052594106,0.09263550401933444,0,0,33.582491582491585,115.77632426352072,SORL1
sphingosine metabolic process (GO:0006670),1/19,0.031824451052594106,0.09263550401933444,0,0,33.582491582491585,115.77632426352072,SPTLC2
maintenance of protein localization in organelle (GO:0072595),1/19,0.031824451052594106,0.09263550401933444,0,0,33.582491582491585,115.77632426352072,HSPA5
regulation of mitochondrial membrane permeability (GO:0046902),1/19,0.031824451052594106,0.09263550401933444,0,0,33.582491582491585,115.77632426352072,SLC25A5
DNA alkylation (GO:0006305),1/19,0.031824451052594106,0.09263550401933444,0,0,33.582491582491585,115.77632426352072,FOS
DNA methylation or demethylation (GO:0044728),1/19,0.031824451052594106,0.09263550401933444,0,0,33.582491582491585,115.77632426352072,FOS
negative regulation of amyloid precursor protein catabolic process (GO:1902992),1/19,0.031824451052594106,0.09263550401933444,0,0,33.582491582491585,115.77632426352072,SORL1
protein targeting to lysosome (GO:0006622),1/20,0.033471909401101146,0.09327233290428795,0,0,31.8133971291866,108.07165990908112,SORL1
regulation of smooth muscle cell migration (GO:0014910),1/20,0.033471909401101146,0.09327233290428795,0,0,31.8133971291866,108.07165990908112,SORL1
regulation of T cell migration (GO:2000404),1/20,0.033471909401101146,0.09327233290428795,0,0,31.8133971291866,108.07165990908112,SPN
positive regulation of cyclin-dependent protein kinase activity (GO:1904031),1/20,0.033471909401101146,0.09327233290428795,0,0,31.8133971291866,108.07165990908112,CCND2
positive regulation of protein processing (GO:0010954),1/20,0.033471909401101146,0.09327233290428795,0,0,31.8133971291866,108.07165990908112,ENO1
miRNA metabolic process (GO:0010586),1/20,0.033471909401101146,0.09327233290428795,0,0,31.8133971291866,108.07165990908112,DDX17
organic cation transport (GO:0015695),1/20,0.033471909401101146,0.09327233290428795,0,0,31.8133971291866,108.07165990908112,SLC44A1
cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),2/170,0.033730652339972335,0.09342368557192338,0,0,7.365327380952381,24.96365976423821,CD164;SELL
negative regulation of reproductive process (GO:2000242),1/21,0.035116646880288954,0.09667655195356659,0,0,30.221212121212123,101.21325681429822,DUSP1
positive regulation of developmental process (GO:0051094),2/177,0.036306633811698075,0.09766692560880604,0,0,7.068214285714285,23.436465479032595,ZBTB16;SORL1
regulation of vacuole organization (GO:0044088),1/22,0.03675866784401453,0.09766692560880604,0,0,28.78066378066378,95.0735042734142,ENO1
negative regulation of myeloid cell differentiation (GO:0045638),1/22,0.03675866784401453,0.09766692560880604,0,0,28.78066378066378,95.0735042734142,ZBTB16
regulation of chromosome organization (GO:0033044),1/22,0.03675866784401453,0.09766692560880604,0,0,28.78066378066378,95.0735042734142,SMG1
mitochondrial calcium ion homeostasis (GO:0051560),1/22,0.03675866784401453,0.09766692560880604,0,0,28.78066378066378,95.0735042734142,PDZD8
peptidyl-threonine dephosphorylation (GO:0035970),1/22,0.03675866784401453,0.09766692560880604,0,0,28.78066378066378,95.0735042734142,DUSP1
regulation of immune response (GO:0050776),2/179,0.037056325973216946,0.09788867612578117,0,0,6.987641242937853,23.026487389719286,SPN;SELL
hyaluronan metabolic process (GO:0030212),1/23,0.038397976622418103,0.10027357323682898,0,0,27.47107438016529,89.54884880069255,CD44
DNA methylation (GO:0006306),1/23,0.038397976622418103,0.10027357323682898,0,0,27.47107438016529,89.54884880069255,FOS
glucose catabolic process to pyruvate (GO:0061718),1/24,0.04003457755707583,0.10108177869383235,0,0,26.27536231884058,84.55442492330164,ENO1
canonical glycolysis (GO:0061621),1/24,0.04003457755707583,0.10108177869383235,0,0,26.27536231884058,84.55442492330164,ENO1
positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),1/24,0.04003457755707583,0.10108177869383235,0,0,26.27536231884058,84.55442492330164,HSPA5
potassium ion homeostasis (GO:0055075),1/24,0.04003457755707583,0.10108177869383235,0,0,26.27536231884058,84.55442492330164,SLC12A6
"wound healing, spreading of cells (GO:0044319)",1/24,0.04003457755707583,0.10108177869383235,0,0,26.27536231884058,84.55442492330164,CD44
"protein alpha-1,2-demannosylation (GO:0036508)",1/24,0.04003457755707583,0.10108177869383235,0,0,26.27536231884058,84.55442492330164,EDEM1
glycolytic process through glucose-6-phosphate (GO:0061620),1/25,0.041668474974439,0.10199974563114765,0,0,25.17929292929293,80.0200555972378,ENO1
regulation of heterotypic cell-cell adhesion (GO:0034114),1/25,0.041668474974439,0.10199974563114765,0,0,25.17929292929293,80.0200555972378,CD44
positive regulation of T cell migration (GO:2000406),1/25,0.041668474974439,0.10199974563114765,0,0,25.17929292929293,80.0200555972378,SPN
negative regulation of cell development (GO:0010721),1/26,0.043299673200093314,0.10199974563114765,0,0,24.170909090909092,75.88723251587066,SORL1
regulation of telomere maintenance (GO:0032204),1/26,0.043299673200093314,0.10199974563114765,0,0,24.170909090909092,75.88723251587066,SMG1
negative regulation of interleukin-1 beta production (GO:0032691),1/26,0.043299673200093314,0.10199974563114765,0,0,24.170909090909092,75.88723251587066,SERPINB1
positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),1/26,0.043299673200093314,0.10199974563114765,0,0,24.170909090909092,75.88723251587066,CCND2
negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),1/26,0.043299673200093314,0.10199974563114765,0,0,24.170909090909092,75.88723251587066,CD44
negative regulation of macroautophagy (GO:0016242),1/26,0.043299673200093314,0.10199974563114765,0,0,24.170909090909092,75.88723251587066,SMG1
regulation of chondrocyte differentiation (GO:0032330),1/26,0.043299673200093314,0.10199974563114765,0,0,24.170909090909092,75.88723251587066,ZBTB16
TOR signaling (GO:0031929),1/26,0.043299673200093314,0.10199974563114765,0,0,24.170909090909092,75.88723251587066,SMG1
regulation of mitotic metaphase/anaphase transition (GO:0030071),1/26,0.043299673200093314,0.10199974563114765,0,0,24.170909090909092,75.88723251587066,DUSP1
regulation of monocyte chemotaxis (GO:0090025),1/26,0.043299673200093314,0.10199974563114765,0,0,24.170909090909092,75.88723251587066,DUSP1
cellular response to cadmium ion (GO:0071276),1/27,0.0449281765490304,0.10422424712135478,0,0,23.24009324009324,72.10680817166444,FOS
cellular response to unfolded protein (GO:0034620),1/27,0.0449281765490304,0.10422424712135478,0,0,23.24009324009324,72.10680817166444,HSPA5
monovalent inorganic cation homeostasis (GO:0055067),1/27,0.0449281765490304,0.10422424712135478,0,0,23.24009324009324,72.10680817166444,SLC12A6
"regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",1/28,0.04655398933456637,0.10532263923711302,0,0,22.378226711560046,68.63721198820747,CD44
cristae formation (GO:0042407),1/28,0.04655398933456637,0.10532263923711302,0,0,22.378226711560046,68.63721198820747,ATP5F1A
regulation of muscle contraction (GO:0006937),1/28,0.04655398933456637,0.10532263923711302,0,0,22.378226711560046,68.63721198820747,ENO1
protein localization to Golgi apparatus (GO:0034067),1/28,0.04655398933456637,0.10532263923711302,0,0,22.378226711560046,68.63721198820747,SORL1
protein localization to lysosome (GO:0061462),1/28,0.04655398933456637,0.10532263923711302,0,0,22.378226711560046,68.63721198820747,SORL1
neutrophil degranulation (GO:0043312),3/481,0.047715010930301054,0.10687835896609116,0,0,3.9454717235794305,12.004134159518012,SERPINB1;SELL;CD44
"positive regulation of transcription, DNA-templated (GO:0045893)",5/1183,0.04798222868193304,0.10687835896609116,0,0,2.7498390024003276,8.35105363659258,DDX17;BCL11B;ZBTB16;FOS;SSBP2
glycolytic process (GO:0006096),1/29,0.048177115857800386,0.10687835896609116,0,0,21.57792207792208,65.4430572478459,ENO1
response to cadmium ion (GO:0046686),1/29,0.048177115857800386,0.10687835896609116,0,0,21.57792207792208,65.4430572478459,FOS
negative regulation of apoptotic process (GO:0043066),3/485,0.04869572025939532,0.10699011614684453,0,0,3.91192611430866,11.822482791415542,CCND2;HSPA5;CD44
neutrophil activation involved in immune response (GO:0002283),3/485,0.04869572025939532,0.10699011614684453,0,0,3.91192611430866,11.822482791415542,SERPINB1;SELL;CD44
neutrophil mediated immunity (GO:0002446),3/488,0.04943783277762485,0.10810090707834716,0,0,3.8871300299301628,11.688752772752258,SERPINB1;SELL;CD44
negative regulation of interleukin-1 production (GO:0032692),1/30,0.04979756042328947,0.10836897673068231,0,0,20.832810867293627,62.494042787714754,SERPINB1
positive regulation of leukocyte cell-cell adhesion (GO:1903039),1/31,0.051415327328444255,0.11031363656854003,0,0,20.13737373737374,59.76407945997836,CD44
cellular nitrogen compound biosynthetic process (GO:0044271),1/31,0.051415327328444255,0.11031363656854003,0,0,20.13737373737374,59.76407945997836,SPTLC2
negative regulation of response to DNA damage stimulus (GO:2001021),1/31,0.051415327328444255,0.11031363656854003,0,0,20.13737373737374,59.76407945997836,CD44
cellular response to topologically incorrect protein (GO:0035967),1/32,0.05303042084188405,0.11272047592902795,0,0,19.486803519061585,57.23058965591193,HSPA5
mitochondrial membrane organization (GO:0007006),1/32,0.05303042084188405,0.11272047592902795,0,0,19.486803519061585,57.23058965591193,SLC25A5
positive regulation of ATP metabolic process (GO:1903580),1/33,0.05464284526670249,0.11507732851098175,0,0,18.876893939393938,54.873941288604264,ENO1
phosphatidylcholine biosynthetic process (GO:0006656),1/33,0.05464284526670249,0.11507732851098175,0,0,18.876893939393938,54.873941288604264,SLC44A1
regulation of amyloid-beta formation (GO:1902003),1/34,0.05625260484794023,0.11685200188867584,0,0,18.30394857667585,52.67698724967126,SORL1
negative regulation of mitochondrion organization (GO:0010823),1/34,0.05625260484794023,0.11685200188867584,0,0,18.30394857667585,52.67698724967126,SLC25A5
positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),1/34,0.05625260484794023,0.11685200188867584,0,0,18.30394857667585,52.67698724967126,FOS
positive regulation of cell cycle G1/S phase transition (GO:1902808),1/35,0.05785970388450594,0.11795837901131599,0,0,17.764705882352942,50.624688080382775,CCND2
negative regulation of neurogenesis (GO:0050768),1/35,0.05785970388450594,0.11795837901131599,0,0,17.764705882352942,50.624688080382775,SORL1
negative regulation of T cell proliferation (GO:0042130),1/35,0.05785970388450594,0.11795837901131599,0,0,17.764705882352942,50.624688080382775,SPN
peptidyl-tyrosine dephosphorylation (GO:0035335),1/35,0.05785970388450594,0.11795837901131599,0,0,17.764705882352942,50.624688080382775,DUSP1
inflammatory response (GO:0006954),2/230,0.05807578835349256,0.11795837901131599,0,0,5.410635964912281,15.398704723100243,FOS;CD44
calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),1/36,0.05946414661556277,0.11918910089172012,0,0,17.256277056277057,48.70380102145059,SELL
regulation of ossification (GO:0030278),1/36,0.05946414661556277,0.11918910089172012,0,0,17.256277056277057,48.70380102145059,ZBTB16
endoderm formation (GO:0001706),1/36,0.05946414661556277,0.11918910089172012,0,0,17.256277056277057,48.70380102145059,DUSP1
negative regulation of endothelial cell proliferation (GO:0001937),1/37,0.061065937308456206,0.12028936788777796,0,0,16.776094276094277,46.90262214500739,ATP5F1A
negative regulation of stress-activated MAPK cascade (GO:0032873),1/37,0.061065937308456206,0.12028936788777796,0,0,16.776094276094277,46.90262214500739,DUSP1
regulation of p38MAPK cascade (GO:1900744),1/37,0.061065937308456206,0.12028936788777796,0,0,16.776094276094277,46.90262214500739,DUSP1
ncRNA metabolic process (GO:0034660),1/37,0.061065937308456206,0.12028936788777796,0,0,16.776094276094277,46.90262214500739,DDX17
negative regulation of lymphocyte proliferation (GO:0050672),1/39,0.06426157953263534,0.1255023155829673,0,0,15.891547049441787,43.619012587141874,SPN
positive regulation of intracellular transport (GO:0032388),1/39,0.06426157953263534,0.1255023155829673,0,0,15.891547049441787,43.619012587141874,SORL1
positive regulation of ossification (GO:0045778),1/40,0.06585543955628825,0.12806781224350525,0,0,15.483294483294483,42.119101454344644,ZBTB16
positive regulation of transcription by RNA polymerase II (GO:0045944),4/908,0.06659958460572248,0.1284296903053574,0,0,2.8115044247787613,7.616525569869946,DDX17;BCL11B;FOS;SSBP2
regulation of response to DNA damage stimulus (GO:2001020),1/41,0.06744666449296668,0.1284296903053574,0,0,15.095454545454546,40.703657605291774,SMG1
gluconeogenesis (GO:0006094),1/41,0.06744666449296668,0.1284296903053574,0,0,15.095454545454546,40.703657605291774,ENO1
carbohydrate catabolic process (GO:0016052),1/41,0.06744666449296668,0.1284296903053574,0,0,15.095454545454546,40.703657605291774,ENO1
import into cell (GO:0098657),1/41,0.06744666449296668,0.1284296903053574,0,0,15.095454545454546,40.703657605291774,SLC12A6
positive regulation of ATPase activity (GO:0032781),1/42,0.0690352585528232,0.1287718904434294,0,0,14.726533628972653,39.36605534679617,DNAJB1
heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),1/42,0.0690352585528232,0.1287718904434294,0,0,14.726533628972653,39.36605534679617,CD164
ceramide biosynthetic process (GO:0046513),1/42,0.0690352585528232,0.1287718904434294,0,0,14.726533628972653,39.36605534679617,SPTLC2
potassium ion import across plasma membrane (GO:1990573),1/42,0.0690352585528232,0.1287718904434294,0,0,14.726533628972653,39.36605534679617,SLC12A6
phosphatidylinositol phosphate biosynthetic process (GO:0046854),1/42,0.0690352585528232,0.1287718904434294,0,0,14.726533628972653,39.36605534679617,SMG1
cellular response to glucose starvation (GO:0042149),1/43,0.07062122597102223,0.1306635638411221,0,0,14.375180375180376,38.10033066830352,HSPA5
substantia nigra development (GO:0021762),1/43,0.07062122597102223,0.1306635638411221,0,0,14.375180375180376,38.10033066830352,HSPA5
hexose biosynthetic process (GO:0019319),1/44,0.0722045709465874,0.131464099293189,0,0,14.04016913319239,36.90110155975086,ENO1
intracellular protein transmembrane transport (GO:0065002),1/44,0.0722045709465874,0.131464099293189,0,0,14.04016913319239,36.90110155975086,HSPA5
intracellular steroid hormone receptor signaling pathway (GO:0030518),1/44,0.0722045709465874,0.131464099293189,0,0,14.04016913319239,36.90110155975086,DDX17
metal ion homeostasis (GO:0055065),1/44,0.0722045709465874,0.131464099293189,0,0,14.04016913319239,36.90110155975086,SLC12A6
negative regulation of T cell activation (GO:0050868),1/45,0.07378529768269645,0.13275543716926094,0,0,13.72038567493113,35.76349947727387,SPN
regulation of insulin receptor signaling pathway (GO:0046626),1/45,0.07378529768269645,0.13275543716926094,0,0,13.72038567493113,35.76349947727387,SORL1
regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),1/45,0.07378529768269645,0.13275543716926094,0,0,13.72038567493113,35.76349947727387,FOS
erythrocyte differentiation (GO:0030218),1/46,0.07536341037599187,0.13453546305401673,0,0,13.414814814814815,34.683110213712276,SLC25A5
regulation of DNA metabolic process (GO:0051052),1/46,0.07536341037599187,0.13453546305401673,0,0,13.414814814814815,34.683110213712276,SMG1
epithelial to mesenchymal transition (GO:0001837),1/47,0.07693891322048374,0.13523493592985025,0,0,13.122529644268775,33.655922697718275,DDX17
positive regulation of cell-cell adhesion (GO:0022409),1/47,0.07693891322048374,0.13523493592985025,0,0,13.122529644268775,33.655922697718275,CD44
glycosphingolipid metabolic process (GO:0006687),1/47,0.07693891322048374,0.13523493592985025,0,0,13.122529644268775,33.655922697718275,ESYT2
positive regulation of neuron death (GO:1901216),1/47,0.07693891322048374,0.13523493592985025,0,0,13.122529644268775,33.655922697718275,FOS
positive regulation of blood vessel endothelial cell migration (GO:0043536),1/48,0.07851181039259558,0.13747087107056008,0,0,12.842682140554482,32.6782845194062,ATP5F1A
"regulation of transcription, DNA-templated (GO:0006355)",7/2244,0.07971286338031512,0.13862697910887753,0,0,2.0547194489975,5.197051849938043,DDX17;BCL11B;ZBTB16;ENO1;FOS;SSBP2;MED12L
cellular defense response (GO:0006968),1/49,0.080082106093531,0.13862697910887753,0,0,12.57449494949495,31.746863166533927,SPN
inner mitochondrial membrane organization (GO:0007007),1/49,0.080082106093531,0.13862697910887753,0,0,12.57449494949495,31.746863166533927,ATP5F1A
chloride transmembrane transport (GO:1902476),1/50,0.0816498044624026,0.1408073986389358,0,0,12.317254174397032,30.85861216573232,SLC12A6
positive regulation of fat cell differentiation (GO:0045600),1/51,0.08321490968036731,0.14243151207463617,0,0,12.07030303030303,30.010741376905646,ZBTB16
mesenchymal cell differentiation (GO:0048762),1/51,0.08321490968036731,0.14243151207463617,0,0,12.07030303030303,30.010741376905646,DDX17
negative regulation of BMP signaling pathway (GO:0030514),1/52,0.08477742591890931,0.14349364312941318,0,0,11.833036244800951,29.200690909254362,SORL1
amide biosynthetic process (GO:0043604),1/52,0.08477742591890931,0.14349364312941318,0,0,11.833036244800951,29.200690909254362,SPTLC2
glycolipid metabolic process (GO:0006664),1/52,0.08477742591890931,0.14349364312941318,0,0,11.833036244800951,29.200690909254362,ESYT2
negative regulation of cysteine-type endopeptidase activity (GO:2000117),1/53,0.08633735729569093,0.14559473167575926,0,0,11.604895104895105,28.42610813491069,CD44
"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",1/54,0.08789470799411693,0.14713509726487706,0,0,11.385363064608347,27.684827361193253,DDX17
regulation of cyclin-dependent protein kinase activity (GO:1904029),1/54,0.08789470799411693,0.14713509726487706,0,0,11.385363064608347,27.684827361193253,CCND2
pyruvate metabolic process (GO:0006090),1/55,0.08944948211911666,0.1475754993806365,0,0,11.173961840628508,26.974851864411704,ENO1
negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),1/55,0.08944948211911666,0.1475754993806365,0,0,11.173961840628508,26.974851864411704,CD44
regulation of blood vessel endothelial cell migration (GO:0043535),1/55,0.08944948211911666,0.1475754993806365,0,0,11.173961840628508,26.974851864411704,ATP5F1A
ceramide metabolic process (GO:0006672),1/55,0.08944948211911666,0.1475754993806365,0,0,11.173961840628508,26.974851864411704,SPTLC2
glycosaminoglycan catabolic process (GO:0006027),1/56,0.09100168383239461,0.1490601057756428,0,0,10.970247933884297,26.29433790784365,CD44
mitochondrial transport (GO:0006839),1/56,0.09100168383239461,0.1490601057756428,0,0,10.970247933884297,26.29433790784365,SLC25A5
regulation of mitotic nuclear division (GO:0007088),1/57,0.09255131724454436,0.15051940206675007,0,0,10.773809523809524,25.641580554578063,DUSP1
protein K48-linked ubiquitination (GO:0070936),1/57,0.09255131724454436,0.15051940206675007,0,0,10.773809523809524,25.641580554578063,TTC3
positive regulation of mitotic cell cycle phase transition (GO:1901992),1/58,0.09409838647736117,0.151953931519979,0,0,10.584263689526848,25.015000999516026,CCND2
membrane lipid biosynthetic process (GO:0046467),1/58,0.09409838647736117,0.151953931519979,0,0,10.584263689526848,25.015000999516026,SPTLC2
negative regulation of autophagy (GO:0010507),1/59,0.09564289565597878,0.15336422215713091,0,0,10.401253918495298,24.41313526094926,SMG1
response to reactive oxygen species (GO:0000302),1/59,0.09564289565597878,0.15336422215713091,0,0,10.401253918495298,24.41313526094926,FOS
cellular response to chemokine (GO:1990869),1/60,0.09718484886207923,0.15529187388101473,0,0,10.224447868515664,23.834624062165258,DUSP1
B cell differentiation (GO:0030183),1/61,0.09872425022238016,0.1572020290997482,0,0,10.053535353535354,23.278203742559715,SLC25A5
glucose metabolic process (GO:0006006),1/62,0.10026110381701644,0.15854437524005716,0,0,9.88822652757079,22.742698109668584,ENO1
regulation of neurogenesis (GO:0050767),1/62,0.10026110381701644,0.15854437524005716,0,0,9.88822652757079,22.742698109668584,SORL1
amyloid fibril formation (GO:1990000),1/63,0.1017954137512644,0.15877305148234752,0,0,9.728250244379277,22.227011088447156,SORL1
negative regulation of peptidase activity (GO:0010466),1/63,0.1017954137512644,0.15877305148234752,0,0,9.728250244379277,22.227011088447156,SERPINB1
cellular response to reactive oxygen species (GO:0034614),1/63,0.1017954137512644,0.15877305148234752,0,0,9.728250244379277,22.227011088447156,FOS
neuropeptide signaling pathway (GO:0007218),1/63,0.1017954137512644,0.15877305148234752,0,0,9.728250244379277,22.227011088447156,SORL1
proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),2/321,0.10305977841553866,0.16006956990086446,0,0,3.8493338557993733,8.747403654847327,HSPA5;EDEM1
negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),1/64,0.10332718407167399,0.16006956990086446,0,0,9.573352573352574,21.73012010811059,ENO1
inorganic anion transmembrane transport (GO:0098661),1/65,0.10485641889528508,0.16188980890251783,0,0,9.423295454545455,21.251070109156853,SLC12A6
extracellular matrix disassembly (GO:0022617),1/66,0.10638312227297914,0.16205695626250488,0,0,9.277855477855478,20.788968145718474,CD44
positive regulation of cell cycle (GO:0045787),1/66,0.10638312227297914,0.16205695626250488,0,0,9.277855477855478,20.788968145718474,CCND2
positive regulation of cell death (GO:0010942),1/66,0.10638312227297914,0.16205695626250488,0,0,9.277855477855478,20.788968145718474,FOS
cellular component disassembly (GO:0022411),1/66,0.10638312227297914,0.16205695626250488,0,0,9.277855477855478,20.788968145718474,CD44
positive regulation of catabolic process (GO:0009896),1/67,0.10790729825957934,0.1632901831279065,0,0,9.13682277318641,20.34297847612108,SORL1
anion transmembrane transport (GO:0098656),1/67,0.10790729825957934,0.1632901831279065,0,0,9.13682277318641,20.34297847612108,SLC25A5
negative regulation of transcription by RNA polymerase II (GO:0000122),3/684,0.10925888231823895,0.1639640346602542,0,0,2.740514423760125,6.067595251303223,DNAJB1;ZBTB16;ENO1
interferon-gamma-mediated signaling pathway (GO:0060333),1/68,0.10942895092205149,0.1639640346602542,0,0,9,19.912318113121092,CD44
regulation of myeloid cell differentiation (GO:0045637),1/68,0.10942895092205149,0.1639640346602542,0,0,9,19.912318113121092,ZBTB16
negative regulation of cellular catabolic process (GO:0031330),1/69,0.11094808432236665,0.16569697560562602,0,0,8.867201426024955,19.49625278180184,SORL1
kidney development (GO:0001822),1/70,0.11246470247248325,0.1674148828336314,0,0,8.738252086078173,19.094093242672443,ZBTB16
regulation of endopeptidase activity (GO:0052548),1/71,0.11397880943867505,0.1685706016617298,0,0,8.612987012987013,18.70519192889038,SERPINB1
regulation of G1/S transition of mitotic cell cycle (GO:2000045),1/71,0.11397880943867505,0.1685706016617298,0,0,8.612987012987013,18.70519192889038,CCND2
negative regulation of epithelial cell proliferation (GO:0050680),1/72,0.11549040925582522,0.17025521622552298,0,0,8.491250533504054,18.328939891769167,ATP5F1A
post-translational protein modification (GO:0043687),2/345,0.11616354280995199,0.1706969101741095,0,0,3.575619533527697,7.6974372232420665,PTP4A2;ZBTB16
negative regulation of protein binding (GO:0032091),1/74,0.11850610347257144,0.1730264833449366,0,0,8.257783312577834,17.612124390060146,SORL1
sphingolipid biosynthetic process (GO:0030148),1/74,0.11850610347257144,0.1730264833449366,0,0,8.257783312577834,17.612124390060146,SPTLC2
integrin-mediated signaling pathway (GO:0007229),1/75,0.1200102059268166,0.1746645353775643,0,0,8.145782145782146,17.270512093187097,FYB1
regulation of T cell proliferation (GO:0042129),1/76,0.1215118172783869,0.17517634225937795,0,0,8.036767676767676,16.939446916298973,SPN
regulation of BMP signaling pathway (GO:0030510),1/76,0.1215118172783869,0.17517634225937795,0,0,8.036767676767676,16.939446916298973,SORL1
chloride transport (GO:0006821),1/76,0.1215118172783869,0.17517634225937795,0,0,8.036767676767676,16.939446916298973,SLC12A6
inorganic cation import across plasma membrane (GO:0098659),1/77,0.12301094154805582,0.17567500089831722,0,0,7.930622009569378,16.618475446932944,SLC12A6
positive regulation of tumor necrosis factor production (GO:0032760),1/77,0.12301094154805582,0.17567500089831722,0,0,7.930622009569378,16.618475446932944,SPN
phosphatidylcholine metabolic process (GO:0046470),1/77,0.12301094154805582,0.17567500089831722,0,0,7.930622009569378,16.618475446932944,SLC44A1
negative regulation of apoptotic signaling pathway (GO:2001234),1/78,0.12450758270134277,0.17725845886141323,0,0,7.827233372687918,16.307169245486165,SLC25A5
regulation of cellular response to heat (GO:1900034),1/79,0.12600174473546216,0.17882856318045406,0,0,7.726495726495727,16.005123167673478,DNAJB1
negative regulation of cell cycle (GO:0045786),1/80,0.12749343166120705,0.17927537928975884,0,0,7.628308400460299,15.711953825485486,DUSP1
negative regulation of cellular response to growth factor stimulus (GO:0090288),1/80,0.12749343166120705,0.17927537928975884,0,0,7.628308400460299,15.711953825485486,SORL1
regulation of fat cell differentiation (GO:0045598),1/80,0.12749343166120705,0.17927537928975884,0,0,7.628308400460299,15.711953825485486,ZBTB16
positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),1/81,0.12898264742204674,0.18081309776648882,0,0,7.532575757575757,15.427298171197009,SPN
regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),1/82,0.13046939599681365,0.1817126584750124,0,0,7.4392068836513285,15.150812179167183,CCND2
regulation of apoptotic process (GO:0042981),3/742,0.13073178540090757,0.1817126584750124,0,0,2.5178314199659524,5.122798676544212,CCND2;HSPA5;CD44
positive regulation of protein phosphorylation (GO:0001934),2/371,0.13081720927413365,0.1817126584750124,0,0,3.3192750677506777,6.751253728024204,CCND2;CD44
regulation of interleukin-1 beta production (GO:0032651),1/83,0.13195368133736293,0.18273585567022685,0,0,7.348115299334811,14.882169637075853,SERPINB1
lymphocyte differentiation (GO:0030098),1/84,0.13343550741856694,0.18367477979001534,0,0,7.259218692953633,14.621061021294857,SLC25A5
vascular transport (GO:0010232),1/84,0.13343550741856694,0.18367477979001534,0,0,7.259218692953633,14.621061021294857,SLC44A1
B cell activation (GO:0042113),1/85,0.13491487818745393,0.18459909979540853,0,0,7.172438672438672,14.367192460983778,SLC25A5
positive regulation of protein catabolic process (GO:0045732),1/85,0.13491487818745393,0.18459909979540853,0,0,7.172438672438672,14.367192460983778,SORL1
negative regulation of cellular amide metabolic process (GO:0034249),1/86,0.1363917975983422,0.1849586097995323,0,0,7.0877005347593585,14.12028477327799,SORL1
positive regulation of endothelial cell migration (GO:0010595),1/86,0.1363917975983422,0.1849586097995323,0,0,7.0877005347593585,14.12028477327799,ATP5F1A
transport across blood-brain barrier (GO:0150104),1/86,0.1363917975983422,0.1849586097995323,0,0,7.0877005347593585,14.12028477327799,SLC44A1
regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),1/87,0.1378662695482398,0.18640498575013487,0,0,7.004933051444679,13.880072573386215,DNAJB1
regulation of cell population proliferation (GO:0042127),3/764,0.13925343078650443,0.18728706526853,0,0,2.442244923911661,4.814787598573125,CD164;CCND2;SLC25A5
negative regulation of binding (GO:0051100),1/88,0.1393382980115978,0.18728706526853,0,0,6.924068268895855,13.64630343816304,SORL1
regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),1/89,0.14080788692300278,0.18760700969041477,0,0,6.845041322314049,13.418737141433665,CD44
transforming growth factor beta receptor signaling pathway (GO:0007179),1/89,0.14080788692300278,0.18760700969041477,0,0,6.845041322314049,13.418737141433665,FOS
post-Golgi vesicle-mediated transport (GO:0006892),1/89,0.14080788692300278,0.18760700969041477,0,0,6.845041322314049,13.418737141433665,SORL1
negative regulation of protein kinase activity (GO:0006469),1/90,0.1422750401804758,0.1884628793115288,0,0,6.7677902621722845,13.197144936653295,SORL1
"regulation of mRNA splicing, via spliceosome (GO:0048024)",1/90,0.1422750401804758,0.1884628793115288,0,0,6.7677902621722845,13.197144936653295,DDX17
regulation of endothelial cell proliferation (GO:0001936),1/92,0.14520205536758202,0.1901356427019627,0,0,6.618381618381618,12.7710212446526,ATP5F1A
cellular response to fibroblast growth factor stimulus (GO:0044344),1/92,0.14520205536758202,0.1901356427019627,0,0,6.618381618381618,12.7710212446526,CD44
T cell activation (GO:0042110),1/92,0.14520205536758202,0.1901356427019627,0,0,6.618381618381618,12.7710212446526,CD44
regulation of peptidyl-tyrosine phosphorylation (GO:0050730),1/92,0.14520205536758202,0.1901356427019627,0,0,6.618381618381618,12.7710212446526,CD44
positive regulation of peptidyl-serine phosphorylation (GO:0033138),1/93,0.1466619251080492,0.19149857078393853,0,0,6.546113306982872,12.56608387020979,CD44
negative regulation of cell death (GO:0060548),1/94,0.14811937485679208,0.19285058207850136,0,0,6.4753991528185075,12.366307690734349,SORL1
regulation of cell migration (GO:0030334),2/408,0.15236788287657052,0.19739971651483873,0,0,3.0110837438423643,5.665225792530103,HSPA5;SORL1
protein maturation (GO:0051604),1/97,0.1524772427346566,0.19739971651483873,0,0,6.272095959595959,11.796181266076253,SORL1
negative regulation of neuron death (GO:1901215),1/98,0.15392505118657634,0.19815140392187436,0,0,6.207122774133083,11.61532352125674,SORL1
regulation of peptidyl-serine phosphorylation (GO:0033135),1/98,0.15392505118657634,0.19815140392187436,0,0,6.207122774133083,11.61532352125674,CD44
mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),1/99,0.15537045897664442,0.19945028020316433,0,0,6.1434755720470005,11.438801065469377,SMG1
cell-matrix adhesion (GO:0007160),1/100,0.1568134700259566,0.20073881176992203,0,0,6.081114172023263,11.266469699963471,CD44
regulation of protein catabolic process (GO:0042176),1/102,0.15969231715146037,0.20385304172686422,0,0,5.96009600960096,10.933833874449698,SORL1
protein targeting to ER (GO:0045047),1/103,0.16112816091877621,0.2051130070748767,0,0,5.90136660724896,10.773270497622093,EDEM1
mRNA transport (GO:0051028),1/104,0.16256162332330876,0.20636294960764473,0,0,5.8437775816416595,10.616379796798373,SMG1
RNA export from nucleus (GO:0006405),1/106,0.16542141923502365,0.20883311765305473,0,0,5.731890331890332,10.313155296299051,SMG1
positive regulation of protein serine/threonine kinase activity (GO:0071902),1/106,0.16542141923502365,0.20883311765305473,0,0,5.731890331890332,10.313155296299051,CCND2
mRNA export from nucleus (GO:0006406),1/107,0.1668477603787351,0.21005351650986762,0,0,5.677530017152659,10.166602529212769,SMG1
negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),1/108,0.16827173541447749,0.21126423924290166,0,0,5.624185783064288,10.023284049176388,SORL1
response to endoplasmic reticulum stress (GO:0034976),1/110,0.1711126023422634,0.21424235416551882,0,0,5.520433694745622,9.745958280916204,HSPA5
Fc-epsilon receptor signaling pathway (GO:0038095),1/111,0.17252950183296037,0.21483918893096157,0,0,5.469972451790634,9.61176465776711,FOS
regulation of protein serine/threonine kinase activity (GO:0071900),1/111,0.17252950183296037,0.21483918893096157,0,0,5.469972451790634,9.61176465776711,CCND2
Fc receptor signaling pathway (GO:0038093),1/112,0.17394405042378158,0.21542664239476472,0,0,5.42042042042042,9.48043229213069,FOS
regulation of macroautophagy (GO:0016241),1/112,0.17394405042378158,0.21542664239476472,0,0,5.42042042042042,9.48043229213069,SMG1
"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",1/113,0.1753562518555918,0.21658866783244718,0,0,5.371753246753247,9.351876727319317,SMG1
cellular response to transforming growth factor beta stimulus (GO:0071560),1/114,0.1767661099055207,0.21774154239035837,0,0,5.323947438991687,9.226016699562276,FOS
positive regulation of protein metabolic process (GO:0051247),1/115,0.1781736283799067,0.21888534454198214,0,0,5.276980329611908,9.102773991144383,SORL1
ion transport (GO:0006811),1/116,0.17957881099881004,0.22002015181355544,0,0,5.230830039525692,8.982073294656722,SLC12A6
regulation of protein binding (GO:0043393),1/118,0.1823821837951678,0.2228573743165553,0,0,5.140896140896141,8.74801045589206,SORL1
cytoskeleton organization (GO:0007010),1/120,0.18517625828747605,0.22566813343300413,0,0,5.053985230455819,8.523279038481911,PDZD8
negative regulation of nucleic acid-templated transcription (GO:1903507),2/464,0.1862001386907688,0.22616023035875085,0,0,2.6385281385281387,4.435189466159759,ZBTB16;ENO1
cellular response to interferon-gamma (GO:0071346),1/121,0.1865698180421205,0.22616023035875085,0,0,5.011616161616161,8.414251704037543,CD44
regulation of anatomical structure morphogenesis (GO:0022603),1/123,0.1893500011715691,0.22892314956456902,0,0,4.9289617486338795,8.202571709503856,PDZD8
regulation of tumor necrosis factor production (GO:0032680),1/124,0.1907366319823037,0.229991136717448,0,0,4.888642522788865,8.099804524943316,SPN
cellular response to oxidative stress (GO:0034599),1/125,0.19212096058411426,0.23028871545632784,0,0,4.848973607038123,7.9990128273347105,FOS
positive regulation of cell population proliferation (GO:0008284),2/474,0.19236119387430148,0.23028871545632784,0,0,2.581302966101695,4.254969360682047,CCND2;SLC25A5
negative regulation of cell growth (GO:0030308),1/126,0.19350299066789908,0.23028871545632784,0,0,4.809939393939394,7.900144172661141,ENO1
negative regulation of growth (GO:0045926),1/126,0.19350299066789908,0.23028871545632784,0,0,4.809939393939394,7.900144172661141,ENO1
phosphatidylinositol biosynthetic process (GO:0006661),1/126,0.19350299066789908,0.23028871545632784,0,0,4.809939393939394,7.900144172661141,SMG1
cellular response to cytokine stimulus (GO:0071345),2/482,0.19731114762808216,0.23421089471697026,0,0,2.537239583333333,4.117872268552753,DUSP1;FOS
cellular response to metal ion (GO:0071248),1/131,0.2003787929533847,0.2372360320717534,0,0,4.623776223776224,7.432931766422354,FOS
RNA metabolic process (GO:0016070),1/133,0.20311315338179647,0.23923379148319843,0,0,4.553259871441689,7.257860033982993,DDX17
transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),1/133,0.20311315338179647,0.23923379148319843,0,0,4.553259871441689,7.257860033982993,FOS
positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),1/134,0.20447692821392519,0.24022096707908433,0,0,4.518796992481203,7.172687055117361,CD44
protein localization to plasma membrane (GO:0072659),1/136,0.20719768525979987,0.2421722305977712,0,0,4.451402918069585,7.00687294182136,FYB1
cellular calcium ion homeostasis (GO:0006874),1/136,0.20719768525979987,0.2421722305977712,0,0,4.451402918069585,7.00687294182136,PDZD8
potassium ion transmembrane transport (GO:0071805),1/139,0.21126189411264842,0.24566586669078963,0,0,4.353974527887571,6.768935718598165,SLC12A6
protein dephosphorylation (GO:0006470),1/139,0.21126189411264842,0.24566586669078963,0,0,4.353974527887571,6.768935718598165,DUSP1
protein localization to cell periphery (GO:1990778),1/140,0.2126121311159233,0.24660848710654049,0,0,4.3224329627207325,6.692361378584255,FYB1
protein localization to organelle (GO:0033365),1/142,0.21530587796347692,0.24855319677689908,0,0,4.260692026649473,6.543125886285318,SORL1
positive regulation of nucleic acid-templated transcription (GO:1903508),2/511,0.21539014940218212,0.24855319677689908,0,0,2.389120825147348,3.6680273493432494,ZBTB16;FOS
receptor-mediated endocytosis (GO:0006898),1/143,0.21664939505598066,0.24855319677689908,0,0,4.230473751600512,6.470403515754424,SORL1
nitrogen compound transport (GO:0071705),1/143,0.21664939505598066,0.24855319677689908,0,0,4.230473751600512,6.470403515754424,SLC44A1
"negative regulation of transcription, DNA-templated (GO:0045892)",3/948,0.21700815210937138,0.24855319677689908,0,0,1.9478750640040963,2.976003179229151,DNAJB1;ZBTB16;ENO1
positive regulation of intracellular protein transport (GO:0090316),1/148,0.22333356081713476,0.2545222875147895,0,0,4.085549371263657,6.124601454172748,SORL1
positive regulation of transferase activity (GO:0051347),1/148,0.22333356081713476,0.2545222875147895,0,0,4.085549371263657,6.124601454172748,SORL1
dephosphorylation (GO:0016311),1/153,0.2299623555726211,0.2614248669071837,0,0,3.9501594896331738,5.806101060955312,DUSP1
regulation of cell differentiation (GO:0045595),1/156,0.23391323954845006,0.2645998774100041,0,0,3.8731182795698924,5.626885615851799,DDX17
peptidyl-serine phosphorylation (GO:0018105),1/156,0.23391323954845006,0.2645998774100041,0,0,3.8731182795698924,5.626885615851799,SMG1
cellular response to growth factor stimulus (GO:0071363),1/158,0.23653622418648415,0.26559472838629794,0,0,3.823393167342212,5.512009728174552,CD44
cellular response to starvation (GO:0009267),1/158,0.23653622418648415,0.26559472838629794,0,0,3.823393167342212,5.512009728174552,HSPA5
T cell receptor signaling pathway (GO:0050852),1/158,0.23653622418648415,0.26559472838629794,0,0,3.823393167342212,5.512009728174552,FYB1
protein autophosphorylation (GO:0046777),1/159,0.23784444567525115,0.26599703831295074,0,0,3.7990026850786345,5.455893670390284,SMG1
negative regulation of cellular macromolecule biosynthetic process (GO:2000113),2/547,0.23805861853390994,0.26599703831295074,0,0,2.2271788990825687,3.196532544389071,ZBTB16;ENO1
regulation of MAPK cascade (GO:0043408),1/166,0.2469412681410595,0.2752491696108883,0,0,3.6365472910927457,5.0860923201364825,DUSP1
peptidyl-serine modification (GO:0018209),1/169,0.25080756543765076,0.27887848517033187,0,0,3.571067821067821,4.9390342910221126,SMG1
cellular protein modification process (GO:0006464),3/1025,0.2520683756906395,0.2796001157539375,0,0,1.7938261473391832,2.4719909052165563,PTP4A2;DUSP1;ZBTB16
nuclear-transcribed mRNA catabolic process (GO:0000956),1/171,0.2533743861607,0.28036826749501187,0,0,3.528698752228164,4.84450498565525,SMG1
positive regulation of ERK1 and ERK2 cascade (GO:0070374),1/172,0.2546545936343233,0.28110422534030377,0,0,3.5078858763069287,4.798251827530825,CD44
defense response to bacterium (GO:0042742),1/176,0.2597541511691116,0.2860425230946603,0,0,3.427012987012987,4.61968090805527,SPN
glycerophospholipid biosynthetic process (GO:0046474),1/177,0.26102373964069236,0.2867496370572029,0,0,3.4073691460055096,4.576587149329015,SLC44A1
RNA processing (GO:0006396),1/179,0.2635565794018977,0.2888377860591541,0,0,3.368743615934627,4.492176530544659,DDX17
antigen receptor-mediated signaling pathway (GO:0050851),1/185,0.2711046464480979,0.29639909910713097,0,0,3.257905138339921,4.252381930846554,FYB1
negative regulation of cell differentiation (GO:0045596),1/191,0.2785776033333182,0.30384239790770035,0,0,3.154066985645933,4.0310824704024695,ZBTB16
protein localization to membrane (GO:0072657),1/195,0.2835182049869584,0.308494808759619,0,0,3.0884098719150264,3.8928756101439714,FYB1
cytokine-mediated signaling pathway (GO:0019221),2/621,0.2850251343638084,0.3093978299388609,0,0,1.9534531502423262,2.4519312460215956,FOS;CD44
negative regulation of intracellular signal transduction (GO:1902532),1/198,0.28720208890875654,0.31068046738890415,0,0,3.040916782033533,3.7937540211642773,DUSP1
positive regulation of cellular process (GO:0048522),2/625,0.2875663844759441,0.31068046738890415,0,0,1.9405096308186196,2.4184601468503137,CCND2;SLC25A5
modification-dependent protein catabolic process (GO:0019941),1/201,0.2908675859437021,0.313505865038377,0,0,2.9948484848484846,3.6982998996245042,TTC3
mitotic cell cycle phase transition (GO:0044772),1/209,0.3005530289055944,0.32318290402319205,0,0,2.8784965034965033,3.460330086551988,CCND2
positive regulation of protein modification process (GO:0031401),1/214,0.30654109869630297,0.3288480800568321,0,0,2.8102148242993312,3.322807681663032,CCND2
extracellular structure organization (GO:0043062),1/216,0.30892236860559336,0.33035030677248034,0,0,2.7837914023960537,3.2700230735710365,CD44
external encapsulating structure organization (GO:0045229),1/217,0.31011002539473537,0.33035030677248034,0,0,2.770763187429854,3.244087464355054,CD44
regulation of cell growth (GO:0001558),1/217,0.31011002539473537,0.33035030677248034,0,0,2.770763187429854,3.244087464355054,ENO1
positive regulation of cell motility (GO:2000147),1/221,0.3148408734720354,0.3346099515737678,0,0,2.7198347107438017,3.1432801505426573,HSPA5
apoptotic process (GO:0006915),1/231,0.3265306538071495,0.3462285586771864,0,0,2.6002635046113305,2.9102966889726396,ZBTB16
regulation of ERK1 and ERK2 cascade (GO:0070372),1/238,0.3345980767903535,0.35396139141942495,0,0,2.5225674466180794,2.7617705057031543,CD44
anterograde trans-synaptic signaling (GO:0098916),1/244,0.34143828970353873,0.36036327573791505,0,0,2.459533607681756,2.642986087339605,SLC12A6
positive regulation of signal transduction (GO:0009967),1/252,0.3504524919828776,0.3690248590695278,0,0,2.380176264638416,2.4956865168842852,SORL1
positive regulation of phosphorylation (GO:0042327),1/253,0.351570811737902,0.36935140451545106,0,0,2.3706108706108706,2.47810416320899,CCND2
positive regulation of cell differentiation (GO:0045597),1/258,0.35713443797356587,0.3743358673255037,0,0,2.3239004834335573,2.392787844858039,ZBTB16
regulation of protein phosphorylation (GO:0001932),1/266,0.36593999909389846,0.3826878251393858,0,0,2.2528301886792454,2.264738414586116,CCND2
central nervous system development (GO:0007417),1/268,0.3681230311187186,0.3840918384046904,0,0,2.235728067188741,2.2342481784046706,ZBTB16
positive regulation of cell migration (GO:0030335),1/269,0.36921180973479023,0.38435033496309595,0,0,2.227272727272727,2.219220667525001,HSPA5
positive regulation of MAPK cascade (GO:0043410),1/274,0.3746284472821137,0.3882204090882675,0,0,2.185925185925186,2.1461862714372018,CD44
"mRNA splicing, via spliceosome (GO:0000398)",1/274,0.3746284472821137,0.3882204090882675,0,0,2.185925185925186,2.1461862714372018,DDX17
regulation of cell cycle (GO:0051726),1/296,0.397930084449716,0.4114344990803625,0,0,2.020647149460709,1.861983826417986,DUSP1
extracellular matrix organization (GO:0030198),1/300,0.40207522606830093,0.4147818923548838,0,0,1.9932096888618627,1.8160453950381168,CD44
chemical synaptic transmission (GO:0007268),1/306,0.40824104809610634,0.4201940517565779,0,0,1.9534028812717337,1.7500487087486432,SLC12A6
protein polyubiquitination (GO:0000209),1/314,0.4163662219062574,0.4275940750812576,0,0,1.9027011327330816,1.6671278289233973,TTC3
cellular response to oxygen-containing compound (GO:1901701),1/323,0.42537762911315474,0.43586900561594555,0,0,1.8486730660643704,1.5802050022576464,FOS
positive regulation of cytokine production (GO:0001819),1/335,0.43718301255926667,0.4469583417641757,0,0,1.7811649428415894,1.4737418913979634,SORL1
intracellular protein transport (GO:0006886),1/336,0.43815609870973893,0.4469583417641757,0,0,1.7757575757575759,1.4653197115654961,SORL1
supramolecular fiber organization (GO:0097435),1/351,0.45255790863202733,0.46062130121344425,0,0,1.6983549783549783,1.3465229953404318,SORL1
ubiquitin-dependent protein catabolic process (GO:0006511),1/354,0.4553949611457212,0.46247888276354354,0,0,1.6836638338054768,1.3243534550832856,TTC3
negative regulation of cell population proliferation (GO:0008285),1/379,0.4784885955284337,0.48485429746451036,0,0,1.5703062369729037,1.1575086906923873,CD164
organelle organization (GO:0006996),1/420,0.5143196428421521,0.5200090194222645,0,0,1.4136833731105807,0.939972683186147,PDZD8
regulation of nucleic acid-templated transcription (GO:1903506),1/430,0.522689607532322,0.5273049683052343,0,0,1.3800240163876527,0.8953146975734522,SSBP2
nervous system development (GO:0007399),1/447,0.5365982997934748,0.5401441035366035,0,0,1.3262671558635684,0.8256086115620377,ZBTB16
regulation of cellular macromolecule biosynthetic process (GO:2000112),1/468,0.5532372315062072,0.5556690435128279,0,0,1.2652650704042567,0.7489969132187179,SSBP2
protein phosphorylation (GO:0006468),1/496,0.5745229155132505,0.5757828341876218,0,0,1.1919804101622284,0.6606137743391447,SMG1
regulation of gene expression (GO:0010468),1/1079,0.8485089277687505,0.8485089277687505,0,0,0.5309495699106088,0.08722156673121978,SSBP2
